Facility 1

Vienna 1130

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Thyroid Cancer

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) — Completed
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early